14-3-3σ expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3274-3279

  Perathoner, Alexander ^a   Pirkebner, Daniela ^a   Brandacher, Gerald ^a   Spizzo, Gilbert ^a   Stadlmann, Sylvia ^a   Obrist, Peter ^a   Margreiter, Raimund ^a   Amberger, Albert ^a,b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN 14 3 3;

ANTIGEN EXPRESSION; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WESTERN BLOTTING; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELL LINE;

14-3-3 PROTEINS; BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 18244386009     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2207     Document Type: Article

References (34)

1. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004;117:1875-84.
2. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000;40:617-47.
3. Mackintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 2004;381:329-42.
4. Muslin AJ, Xing H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 2000;12:703-9.
5. Yaffe MB, Rittinger K, Volinia S, et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997;91:961-71.
6. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003;3:931-43.
7. 2/M progression. Mol Cell 1997;1:3-11.
8. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 1999;401: 616-20.
9. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3σ negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106-12.
10. Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 2000;97:6049-54.
11. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Hypermethylation of 14-3-3σ (stratifin) is an early event in breast cancer. Oncogene 2001;20:3348-53.
12. Iwata N, Yamamoto H, Sasaki S, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-302.
13. Gasco M, Bell AK, Heath V, et al. Epigeneticinactivation of 14-3-3σ in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res 2002;62:2072-6.
14. Osada H, Tatematsu Y, Yatabe Y, et al. Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers. Oncogene 2002;21:2418-24.
15. Cheng L, Pan CX, Zhang JT, et al. Loss of 14-3-3σ in prostate cancer and its precursors. Clin Cancer Res 2004;10:3064-8.
16. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K. Inactivation of the 14-3-3σ gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res 2000;60:4353-7.
17. Ide M, Nakajima T, Asao T, Kuwano H. Inactivation of 14-3-3σ by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front. Cancer Lett 2004;207:241-9.
18. Melis R, White R. Characterization of colonic polyps by two-dimensional gel electrophoresis. Electrophoresis 1999;20:1055-64.
19. Lesuffleur T, Kornowski A, Luccioni C, et al. Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int J Cancer 1991; 49:721-30.
20. Pirkebner D, Fuetsch M, Wittmann W, et al. Reduction of intracellular pH inhibits constitutive expression of cyclooxygenase-2 in human colon cancer cells. J Cell Physiol 2004;198:295-301.
21. Gekle M, Schwerdt G, Freudinger R, et al. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 2000;293:837-44.
22. Gastl G, Spizzo G, Obrist P, Dunser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 2000;356:1981-2.
23. Urano T, Saito T, Tsukui T, et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 2002;417:871-5.
24. Kaneuchi M, Sasaki M, Tanaka Y, et al. Expression and methylation status of 14-3-3σ gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun 2004;316: 1156-62.
25. Gasco M, Sullivan A, Repellin C, et al. Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 2002;21: 1876-81.
26. Lodygin D, Yazdi AS, Sander CA, Herzinger T, Hermeking H. Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003;22:5519-24.
27. Din FV, Dunlop MG, Stark LA. Evidence for colorectal cancer cell specificity of aspirin effects on NF κB signalling and apoptosis. Br J Cancer 2004;91:381-8.
28. Mariadason JM, Arango D, Shi Q, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 2003;63:8791-812.
29. Audic Y, Hartley RS. Post-transcriptional regulation in cancer. Biol Cell 2004;96:479-98.
30. Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. 14-3-3σ mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J Biol Chem 2004;279: 34353-60.
31. 2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax. J Biol Chem 2001;276:45201-6.
32. Nita ME, Nagawa H, Tominaga O, et al. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer 1998;78:986-92.
33. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-92.
34. Edler D, Glimelius B, Hallstrom M, et al. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 2002; 290:1721-8.